Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours Β· Estimated delivery Aug 27 - Sep 1
Sharing injection pens or cartridges can allow disease such as hepatitis or HIV to pass from one person to another
Table 6: Results at Week 52 in a Trial of MOUNJARO versus Insulin Glargine in Adult Patients with Type 2 Diabetes Mellitus Added to Metformin and/or Sulfonylurea and/or SGLT2 Inhibitor MOUNJARO Use In Combination With Basal Insulin With Or Without Metformin In Adult Patients With Type 2 Diabetes Mellitus SURPASS-5 (NCT04039503) was a 40-week double-blind trial that randomized 475 patients with type 2 diabetes mellitus with inadequate glycemic control on insulin glargine 100 units/mL, with or without metformin, to MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or placebo
S.BhansaliA
Frequently Asked Questions Are GLP-1 Side Effects Different For Diabetes Versus Weight Loss Use
US$ 28.32
US$ 21.83
US$ 22.27
US$ 26.99
US$ 26.81
US$ 26.67
